{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:54:18Z","timestamp":1787727258742,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Netherlands Ministry of Health Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jtha.2024.11.012","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T17:11:10Z","timestamp":1732900270000},"page":"836-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring red blood cells as an antigen delivery system to modulate the immune response towards FVIII in hemophilia A"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3763-0151","authenticated-orcid":false,"given":"Mariarosaria","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelke","family":"Brandsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Robben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Van Dender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris P.J.","family":"van Alphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Fijnvandraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje","family":"van den Biggelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Lacroix-Desmazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"van Bruggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4585-2621","authenticated-orcid":false,"given":"Jan","family":"Voorberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.11.012_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.012_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1055\/s-0042-1756188","article-title":"The more recent history of hemophilia treatment","volume":"48","author":"Franchini","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.11.012_bib3","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor VIII: recent progress","volume":"10","author":"Lacroix-Desmazes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/hae.14077","article-title":"Inhibitors\u2014recent insights","volume":"27","author":"Pratt","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.11.012_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/hae.14982","article-title":"Haemophilia in the era of novel therapies: where do inhibitors feature in the new landscape?","volume":"30","author":"Meeks","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.11.012_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2024.11.012_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/hae.14524","article-title":"Emicizumab state-of-the-art update","volume":"28","author":"Mahlangu","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.11.012_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jth.13936","article-title":"Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A mice","volume":"16","author":"Lai","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.012_bib10","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A","volume":"7","author":"Navarrete","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.012_bib11","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","article-title":"Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A","volume":"130","author":"Zerra","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.11.012_bib12","first-page":"290","article-title":"Factor VIII Trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen presenting cells","volume":"142","author":"Kaczmarek","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.11.012_bib13","doi-asserted-by":"crossref","first-page":"e17488","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jtha.2024.11.012_bib14","doi-asserted-by":"crossref","first-page":"115141","DOI":"10.1016\/j.addr.2023.115141","article-title":"Cell and biomaterial delivery strategies to induce immune tolerance","volume":"203","author":"Scotland","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtha.2024.11.012_bib15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.tips.2023.10.002","article-title":"Emerging approaches to induce immune tolerance to therapeutic proteins","volume":"44","author":"Noel","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jtha.2024.11.012_bib16","doi-asserted-by":"crossref","first-page":"114394","DOI":"10.1016\/j.addr.2022.114394","article-title":"Cell-based drug delivery systems and their in\u00a0vivo fate","volume":"187","author":"Yang","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtha.2024.11.012_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12951-023-02060-5","article-title":"Red blood cells: a potential delivery system","volume":"21","author":"Chen","year":"2023","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.jtha.2024.11.012_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.7150\/thno.11852","article-title":"Cell or cell membrane-based drug delivery systems","volume":"5","author":"Tan","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.jtha.2024.11.012_bib19","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","article-title":"Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jtha.2024.11.012_bib20","doi-asserted-by":"crossref","first-page":"655393","DOI":"10.3389\/fphys.2021.655393","article-title":"How do red blood cells die?","volume":"12","author":"Thiagarajan","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jtha.2024.11.012_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1348-0421.12228","article-title":"Functions and development of red pulp macrophages","volume":"59","author":"Kurotaki","year":"2015","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib22","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4049\/jimmunol.1001345","article-title":"CSF-1\u2013dependent red pulp macrophages regulate CD4 T cell responses","volume":"186","author":"Kurotaki","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib23","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1073\/pnas.1216353110","article-title":"Engineering antigens for in situ erythrocyte binding induces T-cell deletion","volume":"110","author":"Kontos","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.11.012_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500112","article-title":"Engineered binding to erythrocytes induces immunological tolerance to E.\u00a0coli asparaginase","volume":"1","author":"Lorentz","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2024.11.012_bib25","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.1701746114","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease","volume":"114","author":"Pishesha","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.11.012_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe1801","article-title":"Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction","volume":"6","author":"Watkins","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drudis.2014.09.017","article-title":"Therapeutic applications of the cell-penetrating HIV-1 Tat peptide","volume":"20","author":"Rizzuti","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jtha.2024.11.012_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1189\/jlb.71.4.652","article-title":"Erythrocytes deliver Tat to interferon-gamma-treated human dendritic cells for efficient initiation of specific type 1 immune responses in\u00a0vitro","volume":"71","author":"Corinti","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jtha.2024.11.012_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/bloodadvances.2017004671","article-title":"Human and murine splenic neutrophils are potent phagocytes of IgG-opsonized red blood cells","volume":"1","author":"Meinderts","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.11.012_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/hae.12348","article-title":"Predictive immunogenicity of Refacto AF","volume":"20","author":"Delignat","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.11.012_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fimmu.2020.00393","article-title":"Removal of mannose-ending glycan at Asn2118 abrogates FVIII presentation by human monocyte-derived dendritic cells","volume":"11","author":"Delignat","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib32","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.002246","article-title":"HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII","volume":"10","author":"van Haren","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jtha.2024.11.012_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00232-016-9940-z","article-title":"Progress in research and application of HIV-1 TAT-derived cell-penetrating peptide","volume":"250","author":"Zou","year":"2017","journal-title":"J\u00a0Membr Biol"},{"key":"10.1016\/j.jtha.2024.11.012_bib34","doi-asserted-by":"crossref","first-page":"e80239","DOI":"10.1371\/journal.pone.0080239","article-title":"Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII","volume":"8","author":"van Haren","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2024.11.012_bib35","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3389\/fimmu.2020.01393","article-title":"Fc gamma receptors and their role in antigen uptake, presentation, and T cell activation","volume":"11","author":"Junker","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fimmu.2014.00674","article-title":"Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all?","volume":"5","author":"Nagelkerke","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.11.012_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000342231","article-title":"CD47 in erythrocyte ageing and clearance\u2014the Dutch point of view","volume":"39","author":"Burger","year":"2012","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.jtha.2024.11.012_bib38","first-page":"1579","article-title":"Hemolysis in the spleen drives erythrocyte turnover","volume":"136","author":"Klei","year":"2020","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T04:56:34Z","timestamp":1741496194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624007025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538783624007025"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.11.012","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring red blood cells as an antigen delivery system to modulate the immune response towards FVIII in hemophilia A","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}